Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons
- PMID: 10367950
- DOI: 10.1016/s0264-410x(98)00474-5
Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons
Abstract
DNA immunization with HIV envelope plasmids induce only moderate levels of specific antibodies which may in part be due to limitations in expression influenced by a species-specific and biased HIV codon usage. We compared antibody levels, Th1/Th2 type and CTL responses induced by synthetic genes encoding membrane bound gp160 versus secreted gp120 using optimized codons and the efficient gene gun immunization method. The in vitro expression of syn.gp160 as gp120 + gp41 was Rev independent and much higher than a classical wt.gp160 plasmid. Mice immunized with syn.gp160 and wt.gp160 generated low and inconsistent ELISA antibody titres whereas the secreted gp120 consistently induced faster seroconversion and higher antibody titres. Due to a higher C + G content the numbers of putative CpG immune (Th1) stimulatory motifs were highest in the synthetic gp160 gene. However, both synthetic genes induced an equally strong and more pronounced Th2 response with higher IgG1/IgG2a and IFNgamma/IL-4 ratios than the wt.gp160 gene. As for induction of CTL, synthetic genes induced a somewhat earlier response but did not offer any advantage over wild type genes at a later time point. Thus, optimizing codon usage has the advantage of rendering the structural HIV genes Rev independent. For induction of antibodies the level of expression, while important, seems less critical than optimal contact with antigen presenting cells at locations reached by the secreted gp120 protein. A proposed Th1 adjuvant effect of the higher numbers of CpG motifs in the synthetic genes was not seen using gene gun immunization which may be due to the low amount of DNA used.
Similar articles
-
Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons.AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1997-2008. doi: 10.1089/088922200750054738. AIDS Res Hum Retroviruses. 2000. PMID: 11153083
-
Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.Virology. 2003 Sep 15;314(1):134-46. doi: 10.1016/s0042-6822(03)00459-8. Virology. 2003. PMID: 14517067
-
HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.J Immunol. 2003 Jan 1;170(1):495-502. doi: 10.4049/jimmunol.170.1.495. J Immunol. 2003. PMID: 12496436
-
HIV-1 DNA vaccines.Immunol Lett. 1999 Jan;65(1-2):127-31. doi: 10.1016/s0165-2478(98)00135-7. Immunol Lett. 1999. PMID: 10065638 Review.
-
HIV subtypes and recombination strains--strategies for induction of immune responses in man.Vaccine. 2002 May 6;20(15):1988-93. doi: 10.1016/s0264-410x(02)00084-1. Vaccine. 2002. PMID: 11983260 Review.
Cited by
-
Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques.Vaccines (Basel). 2013 Jul 19;1(3):305-27. doi: 10.3390/vaccines1030305. Vaccines (Basel). 2013. PMID: 26344115 Free PMC article.
-
TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.Immunology. 2004 Sep;113(1):114-20. doi: 10.1111/j.1365-2567.2004.01938.x. Immunology. 2004. PMID: 15312142 Free PMC article.
-
Vaccine development against HIV-1: current perspectives and future directions.Immunol Res. 2002;25(1):53-74. doi: 10.1385/ir:25:1:53. Immunol Res. 2002. PMID: 11868934 Review.
-
C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences.Curr HIV Res. 2005 Apr;3(2):191-8. doi: 10.2174/1570162053506937. Curr HIV Res. 2005. PMID: 15853723 Free PMC article.
-
Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B.Infect Immun. 2005 Sep;73(9):5666-74. doi: 10.1128/IAI.73.9.5666-5674.2005. Infect Immun. 2005. PMID: 16113284 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous